For inquiries or customized services, please reach us at Info@pharmaceutical-era.com
Over the next 5 years, patent cliffs, turbulent geopolitical and legislative changes will continue to impact drug prices and availability, having a ripple effect on revenue globally. So now more than ever, pharma and their supporting partners must keep costs down to weather the storm and capture savings to reinvest in their R&D pipeline and commercialization efforts for the future.
To deliver performance improvements now, global leaders are beginning to experiment with AI to bridge gaps and reinvent new ways of working where a fragmented, non-standardized landscape exists. But progress is slow, and results are limited. On the other hand, organizations that combine operating model changes with AI can deliver more meaningful and sustainable impact. When AI is introduced alone, the return on the investment is less impactful leading to organizational fatigue, decreased momentum and business value.
Join The Hackett Group and functional and operations leaders to supercharge business change and performance, while leveraging AI for maximum impact. In this interactive panel we will discuss:
Event Date | 26-06-2025 |
Event End Date | 26-06-2025 |
Organizer | Reuters Events |
Location | Online |